Clindamycin phosphate

Clindamycin phosphate, 24729-96-2, Cleocin phosphate, Clindets, Cleocin T, Clindagel, Clindesse, Evoclin, Clinda-Derm, Dalacin P, CLINDAMYCIN-2-PHOSPHATE, Clindamycin 2-phosphate, Dalacin T, 7(S)-Chloro-7-deoxylincomycin 2-phosphate, Clinadac, Clindamycin 2-dihydrogen phosphate, U 28508, CLINDAC, XACIATO, DTXSID1048677, U-28,508, CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, EH6D7113I8, U-28508, NSC-618653, DTXCID1028603, CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, VELTIN COMPONENT CLINDAMYCIN PHOSPHATE, CABTREO COMPONENT CLINDAMYCIN PHOSPHATE, IDP-126 COMPONENT CLINDAMYCIN PHOSPHATE, CHEBI:3746, Clindacin, Zindaclin, Clindacin Etz, Clindacin Pac, Clindacin P, Dalacin c phos, NSC618653, ((2R,3R,4S,5R,6R)-6-(2-chloro-1-(((2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino)propyl)-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl) dihydrogen phosphate, clindamycini phosphas, RefChem:54850, Clindamycin Phosphate 1%, Clindamycin Phosphate USP, 1%, Clindamycin Phosphate Gel USP, 1%, Clindamycin Phoaphate Topical USP, 1%, Clindamycin Phosphate Topical USP, 1%, Clindamycin Phoaphate Topical Solution, 1%, Clindamycin Phosphate Topical Solution, 1%, Cleocin Phosphate (0009-6582) (standalone), Clindamycin Phoaphate Topical Solution USP, 1%, Clindamycin Phosphate Topical Solution USP, 1%, CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE, CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, L-THREO-alpha-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, 2-(DIHYDROGEN PHOSPHATE), Methyl 7-chloro-6,7,8-trideoxy-6-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-dihydrogen phosphate, Clindamycin (phosphate), C18H34ClN2O8PS, clindamycin phosphate hydrate, [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate, Evoclin (TN), Dalacin-S (TN), (2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate, [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate, Clindamycin injection, CAS-24729-96-2, EINECS 246-433-0, CLINDAMYCIN PHOSPHATE HYDRATE [JAN], Clindamycin dihydrogenphosphat, UNII-EH6D7113I8, MFCD07793328, Clindamycin-2-dihydrogenphosphat, NCGC00163494-01, NCGC00166320-01, clindamycin-phosphate, Clindamycin phosphate [USAN:USP:JAN], Clindamycin phosphate CRS, SCHEMBL37148, Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate), orb1309626, orb3139470, CHEMBL3184512, Clindamycin phosphate (Standard), HY-B1064R, MSK7833, BDBM241975, CLINDAMYCIN (AS PHOSPHATE), GLXC-07737, Clindamycin phosphate (JP18/USP), CLINDAMYCIN PHOSPHATE [JAN], HY-B1064, CLINDAMYCIN PHOSPHATE [USAN], Tox21_113055, Tox21_113410, Clindamycin Phosphate (U-28508E), CLINDAMYCIN PHOSPHATE [VANDF], MSK7833-100M, s2048, CLINDAMYCIN PHOSPHATE [MART.], AKOS008901431, CLINDAMYCIN PHOSPHATE [USP-RS], CLINDAMYCIN PHOSPHATE [WHO-DD], CLINDAMYCIN PHOSPHATE [WHO-IP], MSK7833-1000M, AM20485, CCG-269736, Clindamycin phosphate system suitability, CS-4620, NSC 618653, NCGC00386379-01, AS-12554, L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-, Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate), CLINDAMYCIN PHOSPHATE [ORANGE BOOK], DUAC COMPONENT CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE [EP MONOGRAPH], ZIANA COMPONENT CLINDAMYCIN PHOSPHATE, ACANYA COMPONENT CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE [USP MONOGRAPH], CLINDAMYCINI PHOSPHAS [WHO-IP LATIN], BENZACLIN COMPONENT CLINDAMYCIN PHOSPHATE, CLINDAMYCIN 2-DIHYDROGEN PHOSPHATE [MI], D01073, SBI-0654100.0001, AB01566857_01, Clindamycin phosphate for system suitability CRS, SR-01000872581, SR-01000872581-1, BRD-K27771035-001-02-5, Clindamycin phosphate Solution in Methanol, 1000ug/mL, Clindamycin phosphate Solution in Methanol, 100ug/mL, Q27106184, CLINDAMYCIN PHOSPHATE SYSTEM SUITABILITY [USP-RS], (2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yldihydrogenphosphate, (2S-trans)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-.alpha.-D-galacto-octopyranoside 2-(dihydrogen phosphate), L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, 2-(DIHYDROGEN PHOSPHATE), L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, 2-(DIHYDROGEN PHOSPHATE), (2S-TRANS)-, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE 2-(DIHYDROGEN PHOSPHATE), Methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-2-O-phosphono-1-thio-L-threo-alpha-D-galacto-octopyranoside